DiaSorin
Diasorin Submits Gram-Negative Bacteria Panel for FDA 510(k) Clearance
The firm's Gram-negative blood culture assay is used to identify bacterial pathogens and drug resistances, with results within two hours of a Gram stain.
Diasorin Non-COVID Revenues Jump 8 Percent on Rising Immunodiagnostics, Molecular Testing Business
The firm reported gains in immunodiagnostics and molecular testing revenues in Europe and North America during the first half of 2024, offset by declines elsewhere.
Diasorin Nabs FDA De Novo Clearance for Candida Auris Assay
The firm said that the test can be used to help prevent and control the spread of the fungal pathogen, which is a common cause of hospital-acquired infections.
Diasorin Nabs 510(k) Clearance for Fungemia Panel
The Liaison Plex Yeast Blood Culture Assay is used for the detection of 16 pathogens that are commonly associated with fungal bloodstream infections.
Diasorin Nabs FDA 510(k) Clearance for Expanded Respiratory Panel
The firm said that its NxTag Respiratory Pathogen Panel v2 adds detection of the SARS-CoV-2 virus for a total of 21 viral and bacterial targets.